Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 11:52 am Purchase | 2021-12-31 | 13G | Lionheart Acquisition Corporation II LCAP | MARSHALL WACE LLP | 1,197,522 5.060% | 1,197,522 (New Position) | Filing History |
| 2022-02-14 11:49 am Purchase | 2021-12-31 | 13G | HumanCo Acquisition Corp. HMCO | MARSHALL WACE LLP | 1,806,980 5.780% | 1,806,980 (New Position) | Filing History |
| 2022-02-14 11:47 am Purchase | 2021-12-31 | 13G | Fortress Value Acquisition Corp. IV FVIV | MARSHALL WACE LLP | 3,266,946 5.030% | 3,266,946 (New Position) | Filing History |
| 2022-02-14 11:44 am Purchase | 2021-12-31 | 13G | HH&L Acquisition Co. HHLA | MARSHALL WACE LLP | 2,311,227 5.580% | 2,311,227 (New Position) | Filing History |
| 2022-02-14 11:40 am Unchanged | 2021-12-31 | 13G | Gelesis Holdings, Inc. GLSHQ | MARSHALL WACE LLP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 11:37 am Unchanged | 2021-12-31 | 13G | Decarbonization Plus Acquisition Corporation II DCRN | MARSHALL WACE LLP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 11:17 am Purchase | 2021-12-31 | 13G | FAST Acquisition Corp. FST | MARSHALL WACE LLP | 1,500,000 7.500% | 1,500,000 (New Position) | Filing History |
| 2022-02-14 11:13 am Unchanged | 2021-12-31 | 13G | Dave Inc. DAVE | MARSHALL WACE LLP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 11:10 am Purchase | 2021-12-31 | 13G | Quanergy Systems, Inc. QNGY | MARSHALL WACE LLP | 30,390 0.730% | 30,390 (New Position) | Filing History |
| 2022-02-14 11:03 am Purchase | 2021-12-31 | 13G | Apollo Strategic Growth Capital APSG | MARSHALL WACE LLP | 6,109,059 7.480% | 6,109,059 (New Position) | Filing History |
| 2022-02-14 11:01 am Purchase | 2021-12-31 | 13G | AEA-Bridges Impact Corp. IMPX | MARSHALL WACE LLP | 2,012,116 5.030% | 2,012,116 (New Position) | Filing History |
| 2021-02-16 09:56 am Sale | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | MARSHALL WACE LLP | 1,370,352 4.900% | -157,749 (-10.32%) | Filing History |
| 2021-02-04 4:05 pm Purchase | 2021-01-25 | 13G | VG Acquisition Corp. VGAC | MARSHALL WACE LLP | 2,626,787 5.200% | 2,626,787 (New Position) | Filing History |
| 2020-06-15 4:44 pm Purchase | 2020-06-03 | 13G | Esperion Therapeutics, Inc. ESPR | MARSHALL WACE LLP | 1,528,101 5.500% | 1,528,101 (New Position) | Filing History |